Search and Browse
Download
Enter Data
BDBM321290 N-(1-(2-chloroacetyl)piperidin-4-yl)-5- cyclopropylisoxazole-3-carboxamide::US10179773, Compound 4::US10669243, Compound 4
SMILES: c1c(onc1C(=O)NC2CCN(CC2)C(=O)CCl)C3CC3
InChI Key: InChIKey=OENTXAYVUCLRJQ-UHFFFAOYSA-N
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Histone-lysine N-methyltransferase SMYD3 (Human) | BDBM321290![]() (N-(1-(2-chloroacetyl)piperidin-4-yl)-5- cyclopropy...) | GoogleScholar | UniChem | n/a | n/a | 3.35E+4 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase SMYD3 (Human) | BDBM321290![]() (N-(1-(2-chloroacetyl)piperidin-4-yl)-5- cyclopropy...) | GoogleScholar | UniChem | n/a | n/a | 3.35E+4 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase SMYD3 (Human) | BDBM321290![]() (N-(1-(2-chloroacetyl)piperidin-4-yl)-5- cyclopropy...) | GoogleScholar | UniChem | n/a | n/a | n/a | 1.30E+4 | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase SMYD3 (Human) | BDBM321290![]() (N-(1-(2-chloroacetyl)piperidin-4-yl)-5- cyclopropy...) | GoogleScholar | UniChem | n/a | n/a | 370 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase SMYD3 (Human) | BDBM321290![]() (N-(1-(2-chloroacetyl)piperidin-4-yl)-5- cyclopropy...) | GoogleScholar | UniChem | 6.11E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||